AURX
Nuo Therapeutics, Inc. · Healthcare · Market cap $63.0M
Insiders bought $10K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Aug 31, 2026
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$300K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Aug 31, 2026
JORDEN DAVID EMERSON
Nuo Therapeutics, Inc. (AURX) has 11 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 31, 2026.
Inside the rolling window, 1 insider at Nuo Therapeutics, Inc. reported 2 open-market purchases totaling $10K and 1 open-market sale totaling $300K. The most active filer is CEO/CFO JORDEN DAVID EMERSON with 3 filings. The most recent open-market filing is a purchase of 789 shares by CEO/CFO JORDEN DAVID EMERSON, dated Aug 27, 2026, worth $844.
- Industry:Biotechnology
- CEO:David E. Jorden
- Employees:10
- HQ:Houston, TX, US
- IPO:2017-10-24
| Source | |||||||
|---|---|---|---|---|---|---|---|
JORDEN DAVID EMERSONFirst in 9 months | CEO/CFO | Purchase | 789 | $844 | Aug 31 | +14.0% | SEC ↗ |
JORDEN DAVID EMERSONFirst in 9 months | CEO/CFO | Purchase | 7,984 | $9K | Aug 31 | +14.0% | SEC ↗ |
JORDEN DAVID EMERSONFirst filing | CEO/CFO | Sale | 200,000 | $300K | Dec 3 | -42.5% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does AURX have?
Nuo Therapeutics, Inc. (AURX) has 11 SEC Form 4 filings (20 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Aug 31, 2026.
When was the most recent SEC Form 4 filing for AURX?
The most recent Form 4 filing for AURX on Tracefour is dated Aug 31, 2026.
Who is the most active insider at AURX?
The most active SEC Form 4 filer at AURX in the rolling window is CEO/CFO JORDEN DAVID EMERSON, with 3 filings.
What is the net insider flow at AURX over the last 6 months?
Over the trailing 180 days, insiders at AURX have net bought $10K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at AURX in the current window?
Inside the rolling window, insiders at AURX bought $10K and sold $300K based on SEC Form 4 filings.
Can I get alerts for AURX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Nuo Therapeutics, Inc. (AURX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Nuo Therapeutics, Inc. is in the Healthcare sector.